News
Stocktwits on MSN1h
Replimune Stock Catches Retail Fire As Analyst Says FDA Shakeup Removes 'Major Obstacle' For Skin Cancer Drug's Potential Approval
Retail trader buzz around Replimune Group surged Wednesday after Cantor Fitzgerald upgraded the stock to ‘Overweight’ from ...
ServiceNow, Inc. (NYSE:NOW) is one of the AI Stocks in the Spotlight Today. On July 28, Cantor Fitzgerald analyst Thomas ...
Crypto investment firm Twenty One Capital is considering plans to issue U.S. dollar loans backed by Bitcoin collateral, ...
Cantor Fitzgerald LP affiliates Newmark Group Inc. and BGC Group Inc. are suing to seize equity from a commercial real estate ...
Replimune (NASDAQ:REPL) stock surges as Cantor Fitzgerald upgrades, citing improved odds for approval of its lead drug after an FDA leadership change. Read more here.
TipRanks on MSN11h
Replimune upgraded to Overweight from Neutral at Cantor Fitzgerald
Cantor Fitzgerald upgraded Replimune (REPL) to Overweight from Neutral. Published first on TheFly – the ultimate source for real-time, ...
Shares of specialty pharmaceutical company Supernus Pharmaceuticals (NASDAQ:SUPN) jumped 3.1% in the morning session after ...
Cantor Fitzgerald upgraded Seagate Technology (NASDAQ:STX) to Overweight from Neutral, saying the hard drive maker remains well-positioned to benefit from rising cloud storage demand even as the ...
Twenty One Capital is reportedly considering offering US dollar loans backed by Bitcoin, as its BTC holdings surpass 43,500 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback